Post-Discharge Monitoring
The Critical 30-Day Window
Hospital readmissions cost the US healthcare system over $25 billion annually. CMS penalizes hospitals for excess readmissions, creating both quality and financial pressure.
The Solution: Daily Monitoring
Patients discharged from the hospital complete daily vital sign checks from home. Clinical teams receive alerts when vitals trend outside expected ranges.
- ✓No devices to ship or set up
- ✓Works on patient's existing smartphone
- ✓Takes less than 60 seconds
- ✓Alerts clinical team to deterioration
- ✓Integrates with care management platforms
High-Impact Conditions
These conditions have the highest readmission rates and benefit most from early detection
Heart Failure
- Elevated HR
- Increased RR
- Decreased HRV
COPD
- Respiratory changes
- Heart rate elevation
- SpO2 decline
Pneumonia
- Respiratory rate
- Heart rate
- SpO2 monitoring
Post-Surgical
- Infection indicators
- Recovery trajectory
- Activity tolerance
Post-Discharge FAQ
How does this help reduce readmissions?
Many readmissions are preceded by subtle vital sign changes that go undetected. Daily monitoring allows clinical teams to identify deterioration early - when intervention can keep patients at home rather than back in the hospital.
What conditions benefit most?
Heart failure, COPD, pneumonia, and surgical recovery patients see the greatest benefit. These conditions often involve gradual deterioration that early detection can interrupt.
How long should post-discharge monitoring last?
Most readmissions occur within 30 days, with the highest risk in the first 7-14 days. We recommend at least daily monitoring for the first week, transitioning to 3x weekly through 30 days.
Do patients actually complete daily vital checks?
Yes - the ease of contactless monitoring drives high compliance. No devices to remember, no complicated setup. Patients simply check vitals from their phone in under a minute. Typical compliance exceeds 80%.
Request A Demo
See how contactless vitals can transform your healthcare delivery.